Electrospun Composites of Polycaprolactone and Porous Silicon Nanoparticles for the Tunable Delivery of Small Therapeutic Molecules

This report describes the use of an electrospun composite of poly(ε-caprolactone) (PCL) fibers and porous silicon (pSi) nanoparticles (NPs) as an effective system for the tunable delivery of camptothecin (CPT), a small therapeutic molecule. Both materials are biodegradable, abundant, low-cost, and m...

Full description

Saved in:
Bibliographic Details
Published in:Nanomaterials (Basel, Switzerland) Switzerland), 2018-03, Vol.8 (4), p.205
Main Authors: McInnes, Steven J P, Macdonald, Thomas J, Parkin, Ivan P, Nann, Thomas, Voelcker, Nicolas H
Format: Article
Language:English
Subjects:
Biodegradability
Biodegradation
Camptothecin
Cell death
Composite materials
Cytotoxicity
drug delivery
Drug delivery systems
Electrospinning
Fibers
Molecular chains
Nanoparticles
poly(ε-caprolactone)
Polycaprolactone
Porous silicon
Silicon
Sodium
Sodium hydroxide
Wettability
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This report describes the use of an electrospun composite of poly(ε-caprolactone) (PCL) fibers and porous silicon (pSi) nanoparticles (NPs) as an effective system for the tunable delivery of camptothecin (CPT), a small therapeutic molecule. Both materials are biodegradable, abundant, low-cost, and most importantly, have no known cytotoxic effects. The composites were treated with and without sodium hydroxide (NaOH) to investigate the wettability of the porous network for drug release and cell viability measurements. CPT release and subsequent cell viability was also investigated. We observed that the cell death rate was not only affected by the addition of our CPT carrier, pSi, but also by increasing the rate of dissolution via treatment with NaOH. This is the first example of loading pSi NPs as a therapeutics nanocarrier into electronspun PCL fibers and this system opens up new possibilities for the delivery of molecular therapeutics.
ISSN:2079-4991
2079-4991
DOI:10.3390/nano8040205